Despite HOB Biotech's falling earnings and price, its P/E st...

Moomoo AI Feb 1, 2024 06:41

Despite HOB Biotech's falling earnings and price, its P/E still surpasses the market. Investors remain bullish, unwilling to sell their stock. Yet, if recent earnings trends persist, shareholders and potential investors could face significant risk and overpayment.

HOB Biotech Group Corp.,Ltd (SHSE:688656) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

3381 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4819

Followers

Following

11K

Visitors